BU-NOT-SET

CONTACT US
Why outsourcing is key to bringing flexibility and capacity to the manufacture of oral solid dosage forms
  • Manufacturing
Eyes
Insight
Can bigger be better?
  • Industry trends
Eyes
Insight
What does 2017 have in store for the pharma industry?
  • Industry trends
Eyes
Insight
Reflecting on 2017 | the factors shaping our industry
  • Industry trends
Eyes
Insight
Protecting against counterfeiting with serialisation
  • Manufacturing
Eyes
Insight
Manufacturing Chemist CDMO roundtable – part two
  • Industry trends
Eyes
Insight
Manufacturing Chemist CDMO roundtable – part one
  • Industry trends
Eyes
Insight
Increased drive to outsource manufacturing in life science
  • Industry trends
  • Manufacturing
Eyes
Insight
Serialisation: the final countdown
  • Manufacturing
Eyes
Insight
Webinar
  • Analytical chemistry
  • Drug product
Ensuring stability excellence for global consumer and OTC products
Insight
  • Industry trends
The impact of the COVID-19 pandemic on global pharmaceutical growth
Insight
  • Industry trends
COVID-19: a year of unprecedented change
Insight
  • Drug product
Oral solids: market and technology trends
Fact sheet
  • Drug product
Oral modified release
Fact sheet
  • Drug product
Semi-solids an overview of current regulatory requirement
Insight
  • Drug substance
API relocation strategies for CDMO’s
Fact sheet
  • Drug product
  • Manufacturing
Clinical trial material
Insight
  • Drug substance
Time and cost-effective solubility improvement